Free Trial
CVE:LBL

Lattice Biologics (LBL) Stock Price, News & Analysis

→ Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad)
Free LBL Stock Alerts
C$0.04
0.00 (0.00%)
(As of 06/3/2021)
Compare
Today's Range
C$0.04
▼
C$0.04
50-Day Range
C$0.04
▼
C$0.04
52-Week Range
C$0.03
▼
C$0.13
Volume
114,000 shs
Average Volume
468,022 shs
Market Capitalization
C$5.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About Lattice Biologics

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologic products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops novel amniotic fluid-based products, such as AmnioBoost and AmnioBlast. The company also offers traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix allografts. Its products are used in a range of applications, including enhancing fusion in spine surgery and breast reconstruction post mastectomy, promotion of bone regeneration in foot and ankle surgery, promotion of skull healing following neurosurgery, enhancing wound repair in burn victims, hernia repair, and subchondral bone defect repair in knee and other joint surgeries, as well as sports medicine indications, such as anterior and posterior cruciate ligament repair. The company is headquartered in Belgrade, Montana.

LBL Stock Price History

LBL Stock News Headlines

January 10, 2024 | seekingalpha.com
IVBIY Innovent Biologics, Inc.
May 7, 2023 | seekingalpha.com
AbCellera Biologics GAAP EPS of -$0.14, revenue of $12M
April 29, 2024 | The Bull Report (Ad)
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
March 28, 2023 | benzinga.com
ADMA Biologics Stock (NASDAQ:ADMA), Analyst Ratings, Price Targets, Predictions
March 2, 2023 | investing.com
Lattice Biologics Ltd (LBLh)
September 23, 2022 | markets.businessinsider.com
Lattice Announces Lattice Connect Partner Ecosystem to Help Organizations Maximize People Success
September 9, 2022 | morningstar.com
Lattice Semiconductor Corp LSCC Stock Quote
October 26, 2021 | finance.yahoo.com
Notice of Lattice Biologics Ltd. Year End 2016 Financial Results Conference Call
See More Headlines
Receive LBL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lattice Biologics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:LBL
CUSIP
N/A
CIK
N/A
Web
www.latticebiologics.com
Phone
+1-604-2356701
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.02
Quick Ratio
0.02

Sales & Book Value

Annual Sales
C$1.56 million
Price / Sales
3.29
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
C$0.00 per share
Price / Book
40.00

Miscellaneous

Outstanding Shares
128,218,000
Free Float
N/A
Market Cap
C$5.13 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Guy S. Cook (Age 56)
    Chairman, Pres & CEO
    Comp: $360k
  • Ms. Donna Medina
    Interim Chief Financial Officer

Key Competitors

View All Competitors

LBL Stock Analysis - Frequently Asked Questions

How have LBL shares performed in 2024?

Lattice Biologics' stock was trading at C$0.04 at the beginning of 2024. Since then, LBL stock has increased by 0.0% and is now trading at C$0.04.
View the best growth stocks for 2024 here.

What other stocks do shareholders of Lattice Biologics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lattice Biologics investors own include Cross Timbers Royalty Trust (CRT), 50904 (GRC.V) (GRC), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Sorrento Therapeutics (SRNE), Arbor Realty Trust (ABR), Advanced Emissions Solutions (ADES) and Archer-Daniels-Midland (ADM).

How do I buy shares of Lattice Biologics?

Shares of LBL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:LBL) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
AI finds its first serious application
Wall Street Star
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
Banyan Hill Publishing
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Protect Your Bank Account Before It’s Too Late
Weiss Ratings
Trump is sounding the alarm
Preserve Gold
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning
American Hartford Gold Group